'His positivity was half the cure': Athletes remember Dubai-based doctor's care, gentle nature
Dr Sadath was from Kerala and was known for his gentle nature, ethical practice, and deep care for his patients. He was a specialist at Medcare Orthopaedics and Spine Hospital and had over 18 years of experience in treating sports injuries, fractures, and trauma cases. For the past 14 years, he was a part of the Aster DM Healthcare group.
Among those deeply affected by his passing is Indian international handball player Vipin Kumar, who had been receiving treatment from Dr Sadath for many years. 'He was more than just a doctor to me. He focused on healing my injuries naturally, through strengthening exercises and avoiding unnecessary surgeries. Whenever I got hurt, he gave me the confidence to recover and keep going. He always reminded me that we were in this together, it was a team effort,' said Vipin.
Vipin had recently returned from an international handball tournament in Taipei and had met Dr Sadath just days before his death. 'He told me he was going on a vacation soon. He was so happy and proud every time I brought home a medal. I even spoke about him during a recent radio interview, thanking him for the role he played in my success,' he added.
Another patient, speaking to Khaleej Times, said Dr Sadath treated everyone like family. 'He wasn't just a doctor; he was a well-wisher. He cared from the heart. He would never suggest unnecessary procedures, and his first step was always to calm us down and lift our spirits before starting any treatment. That positivity alone was half the cure.'
Known for his humility, Dr Sadath had a strong connection with many athletes in the UAE. His colleagues described him as a man with a pure heart who always put his patients first. 'He had a gift for making people feel at ease. You walked into his clinic with pain and walked out with hope,' said a colleague.
Dr Sadath is survived by his three children. His sudden passing has left a void in the medical and sports community.
He is being laid to rest after Asr prayer at Al Qusais Cemetery, with many of his patients and well-wishers attending the funeral.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
43 minutes ago
- Gulf Today
Kerala's Azad Moopen among India's top 5 promoter-investors
Dr. Azad Moopen, Founder & Chairman, Aster DM Healthcare is now among India's top five promoter-investors in India in FY25, with a dividend income of Rs2,594 crore. He is the only entrepreneur from Kerala to be featured on the prestigious list, which includes prominent industrialists like Mukesh Ambani, Anil Agarwal, and Azim Premji. The company had declared a special dividend of Rs.118.0 per equity share, a final dividend of Rs.2.0 per equity share and an interim dividend of Rs.4.0 per equity share in FY25. The promoters currently hold 42% stake in Aster DM Healthcare. This milestone reflects not just personal wealth creation, but the robust financial health and operational performance of Aster DM Healthcare-an integrated healthcare organisation built with the mission of providing accessible, high-quality care across India and GCC. The same year Aster also announced its landmark merger with Quality Care India Ltd. (QCIL). The merger positions Dr. Moopen led Aster DM Quality Care Ltd. (the combined entity) backed by Blackstone among India's top three hospital chains, with 38 hospitals and over 10,300 beds across 27 cities. Unlike many other promoters in the list, Dr. Moopen's rise stems from an enterprise that prioritizes clinical excellence and community care. From a single clinic in Dubai in 1987 to 900+ healthcare facilities across India and GCC and employing over 34,000+ professionals across seven countries, Dr. Moopen's journey exemplifies sustainable, impact-driven entrepreneurship. Dr. Moopen is recipient of Padma Shri, 4th highest civilian award by the Government of India in 2011 and has also been honoured with the 'Pravasi Bharatiya Samman' by the Government of India. Dr. Moopen's initiatives have played a pivotal role in expanding access to healthcare for underserved communities, underscoring his dual legacy as both a compassionate healer and visionary business leader. Recognising the urgent need for quality medical education and infrastructure in Wayanad, he established Dr. Moopen's Medical College, the first medical college in Kerala to be set up in a hilly, tribal, and backward district, marking a transformative step in uplifting healthcare access in Wayanad. He set up Aster Volunteers in 2016 which has grown to become one of the largest volunteering organisations globally with 85,000+ volunteers working to provide disaster and improve medical access to remote areas. Following the devastating floods in Kerala in 2018, he pledged to rebuild lives by constructing homes for those affected, a promise he fulfilled in 2022 by handing 255 homes across the state. During the 2023 landslides in Wayanad, Dr. Moopen led from the front, directing his team and medical professionals to ensure swift deployment of aid and critical healthcare services. As Aster DM Healthcare enters its next phase of growth, Dr. Moopen's journey stands as a powerful example of how healthcare, rooted in purpose, can also become a powerful engine of sustainable financial value.
Zawya
an hour ago
- Zawya
Advancing access to sexual and reproductive health services in South Sudan
In an effort to address severely limited access to sexual and reproductive health and rights (SRHR) services in South Sudan, the Ministry of Health, with support from World Health Organization (WHO) and partners, has been implementing several initiatives to expand access in seven of its 10 states. Years of overlapping humanitarian crises, including infectious disease outbreaks and complex humanitarian crises driven by conflict and climate-related disasters have disrupted health systems, limiting access to essential health services, including SRHR. As a result, South Sudan continues to face some of the gravest SRHR challenges globally. Access to family planning is low, with a modern contraceptive prevalence rate of around 6% and an adolescent birth rate of 97 per 1000 girls between aged 15‒19 years. The country's maternal mortality ratio is estimated at 692 deaths per 100 000 live births, with around 10% linked to complications from unsafe abortion. The country's legislation permits abortion only when the mother's life is at risk. Despite these legal constraints, women may seek unsafe abortion services, often arriving at health facilities with severe post-abortion complications. With only around 40% of births attended by skilled birth attendants, other key contributors to maternal mortality include postpartum haemorrhage, obstructed labour and sepsis ‒ all of which are preventable with timely access to quality health care. Health authorities, with support from WHO and partners, have focused on expanding access to care that responds to people's needs, choices and rights, through resilient primary health systems. This has been done by strengthening coordination, training health workers and improving monitoring. Targeted efforts have focused on equipping health workers with the knowledge and skills they need to deliver better care. In the northwestern states of Warrap and Northern Bahr el Ghazal, in 2024, 50 health workers were trained in maternal and perinatal death surveillance and response, an important step toward strengthening how maternal and newborn deaths are identified, reported and addressed. An additional 50 health workers were trained in family planning in Torit and Wau, expanding access to voluntary contraceptive services in primary health centres. In Torit, Malakal, Renk and Wau states, 94 health workers received specialized training in the clinical management of rape, ensuring that survivors of gender-based violence from refugee, returnee and host communities can access timely, compassionate care. 'The training has also enabled me to diagnose patients with syphilis and other sexually transmitted infections. It has really expanded my knowledge and allowing me to assist many mothers,' says Faida Jackline, a 29-year-old midwife from Kator Primary Health Care Centre in Juba. Improving access to services also means working with communities to create demand and address stigma and misinformation. Because SRHR services have been absent in the past, many people do not know that they are available. Through dialogues, more than 540 local and religious leaders across five states have been oriented on the concepts underpinning SRHR, helping to increase awareness and promote greater use of available services among communities. WHO has supported the development of national post-abortion care guidelines, recognizing the critical role of safe and timely post-abortion care in preventing maternal deaths. The new guidelines focus on the management of complications from both spontaneous and unsafe abortions. Around 15 health workers from selected primary health care facilities were trained in the new guidelines and at least 30% of the 35 targeted health centres have been equipped with the necessary tools and supplies to deliver post-abortion care, including manual vacuum aspirators, beds, speculums and consumables. 'In collaboration with WHO, we have been able to successfully implement cervical cancer screening and post-abortion care management in six health facilities within Juba County. We have trained 14 midwives, who are currently doing excellent job screening patients in these six facilities. We sincerely thank WHO and partners for this collaboration,' says Vivian Hawa, Reproductive Health Coordinator at Central Equatoria State's Ministry of Health. During 2024, the first year of the project 934 women accessed care for post-abortion complications. This includes 68 health clients from primary health facilities, which initially never had the capacity to provide post-abortion care services. 'Previously we never use to provide post-abortion care at this facility, especially manual vacuum aspiration. However, after receiving the training in 2024, we are now able to attend to women who have had unsafe abortions and perform other post-abortion care procedures,' says Kenyi Emmanuel Wani, a 27-year-old midwife from Munuki Primary Healthcare Centre in Juba, the country's capital. As the programme is ending its second year, continued collaboration and investment will be essential to build on these early gains and contribute to longer-term improvements in reproductive health outcomes across the country. 'Access to quality SRHR services is a matter of dignity, rights, and resilience. South Sudan is making important strides to allow women and girls to gain access to the care they need,' says Dr Humphrey Karamagi, WHO Representative to South Sudan. 'WHO is proud to support the Ministry of Health in strengthening the health system and ensuring that no one is left behind.' Distributed by APO Group on behalf of WHO Regional Office for Africa.
Arabian Business
4 hours ago
- Arabian Business
Abu Dhabi's vaccine distribution hub activated with first shipment
The vaccine distribution hub in Abu Dhabi has been launched following the arrival of the facility's first shipments. Developed by the Department of Health – Abu Dhabi (DoH) in partnership with leading global and regional stakeholders, the hub is a strategic milestone in the emirate's vision to strengthen global health security, ensure equitable vaccine access, and build resilient supply chains across the region. The activation of the hub follows an agreement signed between the DoH and GSK during Abu Dhabi Global Healthcare Week in 2024 to establish regional vaccine distribution capabilities in the emirate. The facility becomes GSK's first vaccine distribution centre in the Middle East and the fourth worldwide. Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed by DoH in collaboration with the Abu Dhabi Investment Office (ADIO), GSK, AD Ports Group, Etihad Cargo, and KEZAD Group. Dr Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, commented: 'The operational launch of Abu Dhabi's regional vaccine hub signals our readiness to serve the region with speed, precision, and reliability. 'More than a logistics milestone, this reflects our long-term vision to position Abu Dhabi as a trusted partner in global health where innovation and resilience translate into timely access and measurable public health impact. Through this hub, we are making vaccines more accessible to communities across borders and strengthening the UAE's leadership in preventive, future-ready healthcare.' The hub leverages Abu Dhabi's strategic location, its advanced cold-chain logistics infrastructure, and a regulatory environment that is both agile and supportive of innovation. The hub's activation also marks one of the first major operational milestones under HELM – Abu Dhabi's Life Science Cluster, which was officially launched in April 2025. As the emirate's flagship platform for driving life sciences investment, innovation, and global collaboration, HELM brings together government, industry, and academia to strengthen the capital's position as a preferred global partner in precision health, pharmaceutical manufacturing, and biopharmaceutical logistics. Boyd Chongphaisal, Vice President and General Manager, GSK Gulf, added: 'The launch of our vaccine distribution hub in Abu Dhabi represents a shared commitment to health security, innovation, and access. Through our strategic partnership with DoH and local stakeholders, we are combining scientific excellence with operational strength to ensure timely, efficient delivery of vaccines across the region. 'The integration of this hub under HELM further demonstrates GSK's pioneering stance and alignment with Abu Dhabi's vision for driving impactful outcomes in the life sciences sector on a regional and global scale. This initiative is also a testament to Abu Dhabi's position in the global value chain, strengthening its role in global health and innovation.' The facility will manage a portfolio of more than 20 vaccines, including those for paediatric and adult populations, supporting lifelong immunisation strategies across multiple markets. Designed for scalability, the hub can accommodate emerging vaccine technologies and increased regional demand, while maintaining the highest global quality and safety standards. As operator of the facility, Rafed, has deployed advanced cold-chain and smart distribution technologies that preserve vaccine integrity and ensure end-to-end visibility throughout the logistics process. The hub is fully integrated with Etihad Cargo's PharmaLife network, which connects Abu Dhabi to more than 100 international destinations and offers time-sensitive, temperature-controlled freight services tailored for pharmaceutical products. Mohammad Mustafa Saeed, Chief Executive Officer of Rafed, said: 'As a PureHealth company, Rafed is committed to delivering healthcare excellence through world-class pharmaceutical logistics. The launch of this regional vaccine distribution hub is a tangible expression of our strategy to strengthen health systems, improve access, and build resilience across borders. 'By deploying advanced cold-chain and smart distribution technologies, we are enabling real-time, end-to-end visibility. We remain focused on supporting governments and health partners with confidence and reliability to achieve better health outcomes for communities from Abu Dhabi across the Middle East, Africa, and South Asia.'
